"The transdermal application of oil extracts containing plant-derived cannabinoids significantly reduces diabetic neuropathy, according to clinical data published in the journal Medical Cannabis and Cannabinoids."
"The oral administration of 800 mg of synthetic CBD significantly reduces subjects’ cravings for alcohol, according to placebo-controlled clinical data published in the journal Nature: Molecular Psychiatry.
German researchers assessed the use of CBD versus placebo in 28 subjects who consumed alcohol daily.
“Individuals receiving CBD … reported significantly lower alcohol cravings,” investigators wrote. “No adverse events or serious adverse events were reported by the participants of the study during the test session.”
"Prenatal cannabis exposure is not associated with either adverse birth outcomes or neurodevelopmental delays in children during the first 12 months of life, according to data published in the journal JAACAP Open."
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.